Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Inhalation CDMO Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The inhalation CDMO market has experienced robust expansion in recent years. This sector is projected to grow from $2.2 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The historical increase in the market size can be attributed to factors such as the rising prevalence of asthma and COPD, an increasing demand for inhalation therapies, the growth of biologics and specialized drug formulations, advancements in formulation technologies, and the increasing outsourcing by pharmaceutical companies.
The inhalation cdmo market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $3.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This projected increase during the forecast timeframe stems from factors such as the broadening use of digital and smart inhalers, the progression of personalized medicine and precision therapy, enhanced capital expenditure in inhalation cdmo infrastructure, the growing implementation of advanced manufacturing techniques, and a rise in partnerships between biotechnology companies and CDMOs. Key developments expected within this period encompass the evolution of personalized inhalation therapies, sophisticated formulation and drug delivery methodologies, improved regulatory adherence and quality assurance measures, the growth of contract manufacturing services for small and medium enterprises, and the incorporation of smart inhalers with digital health monitoring systems.
Get A Free Sample Report With In-Depth Market Insights:
Inhalation CDMO Market Growth Factors: What’s Supporting Expansion?
The inhalation CDMO market is anticipated to expand due to the rising occurrence of respiratory conditions. These disorders encompass various medical issues impacting the respiratory system, which comprises the organs and structures essential for breathing. Inhalation CDMOs play a crucial role in developing and manufacturing products for respiratory ailments, leveraging their proficiency in drug formulation and delivery to the lungs. They provide pharmaceutical firms with specialized knowledge, facilities, and assets necessary for introducing innovative inhalation treatments. For example, data from December 2023, released by the National Library of Medicine, a US-based medical library, indicates that worldwide chronic obstructive pulmonary disease (COPD) cases among individuals 25 and older are forecast to increase by 23% by 2050, totaling almost 600 million. Consequently, the growing frequency of respiratory disorders is fueling the expansion of the inhalation CDMO market.
Inhalation CDMO Market Segment Analysis And Revenue Potential
The inhalation cdmo market covered in this report is segmented –
1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs
2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs
3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers
4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices
Inhalation CDMO Market Industry Trends: What’s Reshaping Demand?
Leading companies operating in the inhalation CDMO industry are increasingly adopting a strategic partnership approach to provide specialized drug development and delivery services. Such a partnership constitutes a long-term, mutually beneficial arrangement between two or more organizations working together to achieve shared objectives. For instance, in May 2023, Hovione, a Portugal-based Contract Development and Manufacturing Organization, collaborated with H&T Presspart, a UK-based manufacturer of high-precision metal and plastic components for the pharmaceutical industry, to advance Presspart’s Sunrise Capsule-based Dry Powder Inhaler platform. This alliance is centered on creating new technologies designed to deliver higher drug doses and improve the efficiency of drug delivery to the lungs.
Inhalation CDMO Market Key Players Shaping Industry Direction
Major companies operating in the inhalation cdmo market are Baxter’s BioPharma Solutions, Lonza Group AG, Catalent Inc., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Copley Scientific, Cambrex Corporation, AptarGroup Inc.
View The Full Inhalation CDMO Market Report:
Inhalation CDMO Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the inhalation cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model